POLY MEDICURE LTD.

NSE : POLYMEDBSE : 531768ISIN CODE : INE205C01021Industry : Medical Equipment/Supplies/AccessoriesHouse : Private
BSE1573.606.05 (+0.39 %)
PREV CLOSE ( ) 1567.55
OPEN PRICE ( ) 1536.25
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1095
TODAY'S LOW / HIGH ( )1536.25 1590.85
52 WK LOW / HIGH ( )921 1727
NSE1570.602.2 (+0.14 %)
PREV CLOSE( ) 1568.40
OPEN PRICE ( ) 1570.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 1570.60 (3)
VOLUME 53408
TODAY'S LOW / HIGH( ) 1542.00 1592.00
52 WK LOW / HIGH ( )925 1729
( in Million)
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Profit Before Tax2374.911952.451800.541257.23986.76
Adjustment611.58390.78444.84505.87442.26
Changes In working Capital-499.56-633.94-611.85-120.72-86.94
Cash Flow after changes in Working Capital2486.931709.281633.531642.391342.07
Cash Flow from Operating Activities1908.261234.721187.321283.041064.82
Cash Flow from Investing Activities-1790.16-853.32-4355.83-1072.58-1007.36
Cash Flow from Financing Activities-125.05-353.383169.49-205.07-51.29
Net Cash Inflow / Outflow-6.9528.030.975.406.17
Opening Cash & Cash Equivalents77.5749.5548.5743.1837.01
Cash & Cash Equivalent on Amalgamation / Take over / MergerNANANANANA
Cash & Cash Equivalent of Subsidiaries under liquidationsNANANANANA
Translation adjustment on reserves / op cash balalces frgn subsidiariesNANANANANA
Effect of Foreign Exchange FluctuationsNANANANANA
Closing Cash & Cash Equivalent70.6277.5749.5548.5743.18

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.